SCHEMBL30830707

SCHEMBL30830707

CN1C[C@H](Nc2cnn(C)c(=O)c2Br)C[C@H](c2ccc(CN3CCN(c4ccc5c(c4)C(=O)N(C4CCC(=O)NC4=O)C5=O)CC3)cc2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KAT2B Q92831 6/20 0.51
▸ BRD9 Q9H8M2 4/20 0.51
▸ BRD1 O95696 1/20 0.51
▸ ACHE P22303 1/20 0.51
▸ BRPF1 P55201 1/20 0.51
▸ BPTF Q12830 1/20 0.51
▸ KAT2A Q92830 1/20 0.51
▸ BRD7 Q9NPI1 1/20 0.51
▸ BAZ2B Q9UIF8 1/20 0.51
▸ BRPF3 Q9ULD4 1/20 0.51
▸ CRBN Q96SW2 7/20 0.45
▸ PLK4 O00444 1/20 0.44
▸ DDB1 Q16531 2/20 0.41
▸ IKZF3 Q9UKT9 1/20 0.41
▸ IRAK1 P51617 2/20 0.40
▸ IRAK4 Q9NWZ3 2/20 0.40
▸ IRAK3 Q9Y616 2/20 0.40
▸ CCNC P24863 1/20 0.40
▸ CDK8 P49336 1/20 0.40
▸ NTRK3 Q16288 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830907 0.93 KAT2B (0.48) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830747 0.93 KAT2B (0.51) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830642 0.93 PLK4 (0.46) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830716 0.93 KAT2B (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830499 0.91 KAT2B (0.47) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830983 0.91 KAT2B (0.55) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830516 0.91 KAT2B (0.53) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830919 0.90 CRBN (0.50) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830674 0.90 IKZF2 (0.49) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830766 0.88 KAT2B (0.55) KAT2BBRD9BRD1ACHEBRPF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback